- Home
- XBIT vs ARAY Comparison
XBIT vs ARAY Comparison
Compare XBIT & ARAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XBIT
- ARAY
- Stock Information
- Founded
- XBIT 2005
- ARAY 1990
- Country
- XBIT United States
- ARAY United States
- Employees
- XBIT N/A
- ARAY N/A
- Industry
- XBIT Pharmaceuticals and Biotechnology
- ARAY Medical/Dental Instruments
- Sector
- XBIT Health Care
- ARAY Health Care
- Exchange
- XBIT Nasdaq
- ARAY Nasdaq
- Market Cap
- XBIT 194.5M
- ARAY 180.0M
- IPO Year
- XBIT 2015
- ARAY 2007
- Fundamental
- Price
- XBIT $3.25
- ARAY $2.33
- Analyst Decision
- XBIT
- ARAY Strong Buy
- Analyst Count
- XBIT 0
- ARAY 1
- Target Price
- XBIT N/A
- ARAY $9.00
- AVG Volume (30 Days)
- XBIT 52.0K
- ARAY 626.8K
- Earning Date
- XBIT 03-14-2025
- ARAY 02-05-2025
- Dividend Yield
- XBIT N/A
- ARAY N/A
- EPS Growth
- XBIT N/A
- ARAY N/A
- EPS
- XBIT N/A
- ARAY N/A
- Revenue
- XBIT N/A
- ARAY $444,204,000.00
- Revenue This Year
- XBIT N/A
- ARAY $6.64
- Revenue Next Year
- XBIT N/A
- ARAY $5.69
- P/E Ratio
- XBIT N/A
- ARAY N/A
- Revenue Growth
- XBIT N/A
- ARAY N/A
- 52 Week Low
- XBIT $3.25
- ARAY $1.40
- 52 Week High
- XBIT $9.96
- ARAY $2.95
- Technical
- Relative Strength Index (RSI)
- XBIT 26.88
- ARAY 59.57
- Support Level
- XBIT $3.40
- ARAY $2.15
- Resistance Level
- XBIT $3.69
- ARAY $2.37
- Average True Range (ATR)
- XBIT 0.20
- ARAY 0.12
- MACD
- XBIT 0.05
- ARAY -0.01
- Stochastic Oscillator
- XBIT 3.85
- ARAY 81.82
About XBIT XBiotech Inc.
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. It is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-IL-1 a therapeutic antibody as a treatment for cancer. Geographically, all of its operations are in the United States.
About ARAY Accuray Incorporated
Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, innovative treatment solutions which set the standard of radiation therapy care with the aim of helping patients live better lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention.